BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32597807)

  • 1. Identification of a Cascade of Changes in Activities of Daily Living Preceding Short-Term Clinical Deterioration in Mild Alzheimer's Disease Dementia via Lead-Lag Analysis.
    Fuentes M; Klostermann A; Kleineidam L; Bauer C; Schuchhardt J; Maier W; Jessen F; Frölich L; Wiltfang J; Kornhuber J; Klöppel S; Schieting V; Teipel SJ; Wagner M; Peters O
    J Alzheimers Dis; 2020; 76(3):1005-1015. PubMed ID: 32597807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between Cognition and Activities of Daily Living in Alzheimer's Disease During a 5-Year Follow-Up: ALSOVA Study.
    Saari T; Hallikainen I; Hänninen T; Räty H; Koivisto A
    J Alzheimers Dis; 2018; 64(1):269-279. PubMed ID: 29889073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychiatric Symptoms in Alzheimer's Disease Are the Main Determinants of Functional Impairment in Advanced Everyday Activities.
    Delgado C; Vergara RC; Martínez M; Musa G; Henríquez F; Slachevsky A
    J Alzheimers Dis; 2019; 67(1):381-392. PubMed ID: 30584142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired Cognitive Function is Associated with Motor Function and Activities of Daily Living in Mild to Moderate Alzheimer's Dementia.
    Lee G
    Curr Alzheimer Res; 2020; 17(7):680-686. PubMed ID: 32811414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognition, gender, and functional abilities in Alzheimer's disease: how are they related?
    Benke T; Delazer M; Sanin G; Schmidt H; Seiler S; Ransmayr G; Dal-Bianco P; Uranüs M; Marksteiner J; Leblhuber F; Kapeller P; Bancher C; Schmidt R
    J Alzheimers Dis; 2013; 35(2):247-52. PubMed ID: 23388173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABC Dementia Scale Classifies Alzheimer's Disease Patients into Subgroups Characterized by Activities of Daily Living, Behavioral and Psychological Symptoms of Dementia, and Cognitive Function.
    Wada-Isoe K; Kikuchi T; Umeda-Kameyama Y; Mori T; Akishita M; Nakamura Y;
    J Alzheimers Dis; 2020; 73(1):383-392. PubMed ID: 31771061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive and functional decline and their relationship in patients with mild Alzheimer's dementia.
    Liu-Seifert H; Siemers E; Sundell K; Price K; Han B; Selzler K; Aisen P; Cummings J; Raskin J; Mohs R
    J Alzheimers Dis; 2015; 43(3):949-55. PubMed ID: 25125457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study.
    Hallikainen I; Hänninen T; Fraunberg M; Hongisto K; Välimäki T; Hiltunen A; Karppi P; Sivenius J; Soininen H; Koivisto AM;
    Int Psychogeriatr; 2013 Aug; 25(8):1335-44. PubMed ID: 23676340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy.
    Wattmo C; Minthon L; Wallin ÅK
    Alzheimers Res Ther; 2016 Feb; 8():7. PubMed ID: 26883213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Positive Effects of Pet Ownership on Alzheimer's Disease.
    Rusanen M; Selander T; Kärkkäinen V; Koivisto A
    J Alzheimers Dis; 2021; 84(4):1669-1675. PubMed ID: 34719492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Visit-to-Visit Blood Pressure Variability on Cognitive and Functional Decline in Mild to Moderate Alzheimer's Disease.
    O'Caoimh R; Gao Y; Svendrovski A; Illario M; Iaccarino G; Yavuz BB; Kehoe PG; Molloy DW
    J Alzheimers Dis; 2019; 68(4):1499-1510. PubMed ID: 30909214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.
    Galasko D; Bennett D; Sano M; Ernesto C; Thomas R; Grundman M; Ferris S
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S33-9. PubMed ID: 9236950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of physical and cognitive function in performance of activities of daily living in patients with mild-to-moderate Alzheimer's disease - a cross-sectional study.
    Clemmensen FK; Hoffmann K; Siersma V; Sobol N; Beyer N; Andersen BB; Vogel A; Lolk A; Gottrup H; Høgh P; Waldemar G; Hasselbalch SG; Frederiksen KS
    BMC Geriatr; 2020 Nov; 20(1):513. PubMed ID: 33246408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detailed assessment of activities of daily living in moderate to severe Alzheimer's disease.
    Galasko D; Schmitt F; Thomas R; Jin S; Bennett D;
    J Int Neuropsychol Soc; 2005 Jul; 11(4):446-53. PubMed ID: 16209425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ABC of Alzheimer's disease: ADL and improving day-to-day functioning of patients.
    Potkin SG
    Int Psychogeriatr; 2002; 14 Suppl 1():7-26. PubMed ID: 12636178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of psychotropic medications in relation to neuropsychiatric symptoms, cognition and functional performance in Alzheimer's disease over a three-year period: Kuopio ALSOVA study.
    Törmälehto S; Martikainen J; Bell JS; Hallikainen I; Koivisto AM
    Int Psychogeriatr; 2017 Oct; 29(10):1723-1733. PubMed ID: 28625207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spanish version of the Bayer Activities of Daily Living scale in mild cognitive impairment and mild Alzheimer disease: discriminant and concurrent validity.
    Sánchez-Benavides G; Manero RM; Quiñones-Ubeda S; de Sola S; Quintana M; Peña-Casanova J
    Dement Geriatr Cogn Disord; 2009; 27(6):572-8. PubMed ID: 19602885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodromal and mild Alzheimer's disease.
    Frölich L; Wunderlich G; Thamer C; Roehrle M; Garcia M; Dubois B
    Alzheimers Res Ther; 2019 Feb; 11(1):18. PubMed ID: 30755255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study.
    Kahle-Wrobleski K; Andrews JS; Belger M; Ye W; Gauthier S; Rentz DM; Galasko D
    J Prev Alzheimers Dis; 2017; 4(2):72-80. PubMed ID: 29186278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional assessment staging (FAST) in Korean patients with Alzheimer's disease.
    Na HR; Kim SY; Chang YH; Park MH; Cho ST; Han IW; Kim TY; Hwang SA
    J Alzheimers Dis; 2010; 22(1):151-8. PubMed ID: 20847407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.